Statistics for Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trial
Total visits
| views | |
|---|---|
| Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trial | 0 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |